Activated Protein C Anticoagulant System Dysfunction and Thrombophilia in Asia

키워드

참고문헌 (62)

1. Lane DA, "Inherited thrombophilia: Part 1", Thromb Haemost, 76, pp.651~662 (1996)
2. Lane DA, "Inherited thrombophilia: Part 2", Thromb Haemost, 76, pp.824~834 (1996)
3. Dahlbäck B, "Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C", Proc Natl Acad Sci USA, 90, pp.1004~1008 (1993)
4. Koster T, "Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study", Lancet, 342, pp.1503~1506 (1993)
5. Bertina RM, "Mutation in blood coagulation factor V associated with resistance to activated protein C", Nature, 369, pp.64~67 (1994)
6. Ridker PM, "Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men", N Engl J Med, 332, pp.912~917 (1995)
7. Rosendaal FR, "Risk factors for venous thrombosis: prevalence, risk, and interaction", Semin Hematol, 34, pp.171~187 (1997)
8. Castoldi E, "APC resistance: biological basis and acquired influences", J Thromb Haemost, 8, pp.445~453 (2010)
9. Poort SR, "A common genetic variation in the 3’-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis", Blood, 88, pp.3698~3703 (1996)
10. Franco RF, "Genetic risk factors of venous thrombosis", Hum Genet, 109, pp.369~384 (2001)
11. Bounameaux H, "Venous thromboembolism: Why does ethnicity matter?", Circulation, 123, pp.2189~2191 (2011)
12. Rees DC, "World distribution of factor V Leiden", Lancet, 346, pp.1133~1134 (1995)
13. Seki T, "Arg506Gln mutation of the coagulation factor V gene not detected in Japanese pulmonary thromboembolism", Heart Vessels, 13, pp.195~198 (1998)
14. Isshiki I, "Frequencies of prothrombin 20210 G A mutation may be different among races--studies on Japanese populations with various forms of thrombotic disorders and healthy subjects", Blood Coagul Fibrinolysis, 9, pp.105~106 (1998)
15. Shen MC, "High prevalence of antithrombin III, protein C and protein S deficiency, but no factor V Leiden mutation in venous thrombophilic Chinese patients in Taiwan", Thromb Res, 8, pp.377~385 (1997)
16. Kim YW, "Absence of factor V Leiden mutation in Koreans", Thromb Res, 86, pp.181~182 (1997)
17. Tang L, "Genetic background analysis of protein C deficiency demonstrates a recurrent mutation associated with venous thrombosis in Chinese population", PLoS One, 7, pp.e35773~ (2012)
18. Kinoshita S, "Protein S and protein C gene mutations in Japanese deep vein thrombosis patients", Clin Biochem, 38, pp.908~915 (2005)
19. Liu HW, "High incidence of thrombophilia detected in Chinese patients with venous thrombosis", Thromb Haemost, 71, pp.416~419 (1994)
20. Tsuda H, "Screening for aetiology of thrombophilia: a high prevalence of protein S abnormality", Ann Clin Biochem, 36, pp.423~432 (1999)
21. Miyata T, "More on: racial differences in venous thromboembolism", J Thromb Haemost, 10, pp.319~320 (2012)
22. Trujillo-Santos AJ, "Association between long travel and venous thromboembolic disease: a systematic review and meta-analysis of case-control studies", Ann Hematol, 87, pp.79~86 (2008)
23. "The prevention of venous thromboembolism in hospitalised patients (Second report of session 2004- 2005)"[URL]
24. Bhatia V, "Air travel and pulmonary embolism: “economy class syndrome”", J Assoc Physicians India, 57, pp.412~424 (2009)
25. Ueda S, "High prevalence of deep vein thrombosis in tsunami-flooded shelters established after the great East-Japan earthquake", Tohoku J Exp Med, 227, pp.199~202 (2012)
26. Shigekiyo T, "Protein S Tokushima: an abnormal protein S found in a Japanese family with thrombosis", Thromb Haemost, 70, pp.244~246 (1993)
27. Yamazaki Y, "A phenotypically neutral dimorphism of protein S: the substitution of Lys155 by Glu in the second EGF domain predicted by an A to G base exchange in the gene", Thromb Res, 70, pp.395~403 (1993)
28. Hayashi T, "Protein S Tokushima: abnormal molecule with a substitution of Glu for Lys-155 in the second epidermal growth factor-like domain of protein S", Blood, 83, pp.683~690 (1994)
29. Tsuda H, "Four missense mutations identified in the protein S gene of thrombosis patients with protein S deficiency: effects on secretion and anticoagulant activity of protein S", Thromb Res, 105, pp.233~239 (2002)
30. Kimura R, "Protein S-K196E mutation as a genetic risk factor for deep vein thrombosis in Japanese patients", Blood, 107, pp.1737~1738 (2006)
31. Ikejiri M, "The association of protein S Tokushima-K196E with a risk of deep vein thrombosis", Int J Hematol, 92, pp.302~305 (2010)
32. Hamasaki N, "Japanese thrombophilia: Protein S", Protein C anomaly as the major risk factor for Japanese thrombophilia, 2006, pp.17, 136~143
33. Tatewaki H, "A novel splice acceptor site mutation which produces multiple splicing abnormalities resulting in protein S deficiency type I", Thromb Haemost, 82, pp.65~71 (1999)
34. Nakahara M, "A novel splice acceptor site mutation of protein S gene in affected individuals with type I protein S deficiency: allelic exclusion of the mutant gene", Thromb Res, 101, pp.387~393 (2001)
35. Iida H, "Failure in the detection of aberrant mRNA from the heterozygotic splice site mutant allele for protein S in a patient with protein S deficiency", Thromb Res, 102, pp.187~196 (2001)
36. Tsuda H, "Characterization of endoplasmic reticulum-associated degradation of a protein S mutant identified in a family of quantitative protein S deficiency", Thromb Res, 117, pp.323~331 (2006)
37. Yamazaki T, "A quantitative protein S deficiency associated with a novel nonsense mutation and markedly reduced levels of mutated mRNA", Thromb Haemost, 74, pp.590~595 (1995)
38. Yamazaki T, "Molecular basis of a hereditary type I protein S deficiency caused by a substitution of Cys for Arg474", Blood, 87, pp.4643~4650 (1996)
39. Okamoto Y, "A novel nonsense mutation associated with an exon skipping in a patient with hereditary protein S deficiency type I", Thromb Haemost, 75, pp.877~882 (1996)
40. Yamazaki T, "Two distinct novel splice site mutations in a compound heterozygous patient with protein S deficiency", Thromb Haemost, 77, pp.14~20 (1997)
41. Fujimura H, "Three novel missense mutations in unrelated Japanese patients with type I and type II protein S deficiency and venous thrombosis", Thromb Res, 89, pp.151~160 (1998)
42. Iwaki T, "DNA sequence analysis of protein S deficiency--identification of four point mutations in twelve Japanese subjects", Semin Thromb Hemost, 27, pp.155~160 (2001)
43. Yamazaki T, "Rapid intracellular degradation of a truncated mutant protein S (Q522X)", Thromb Haemost, 87, pp.171~172 (2002)
44. Hirose M, "Nakanishi K, et al. Protein S gene mutation in a young woman with type III protein S deficiency and venous thrombosis during pregnancy", J Thromb Thrombolysis, 13, pp.85~88 (2002)
45. Okada H, "Identification of protein Sα gene mutations including four novel mutations in eight unrelated patients with protein S deficiency", Br J Haematol, 126, pp.219~225 (2004)
46. Okada H, "In vitro characterization of missense mutations associated with quantitative protein S deficiency", J Thromb Haemost, 4, pp.2003~2009 (2006)
47. Mizukami K, "One novel and one recurrent mutation in the PROS1 gene cause type I protein S deficiency in patients with pulmonary embolism associated with deep vein thrombosis", Am J Hematol, 81, pp.787~797 (2006)
48. Sanada N, "An Sp1 binding site mutation of the PROS1 promoter in a patient with protein S deficiency", Br J Haematol, 138, pp.663~665 (2007)
49. Hamasaki N, "Clinical role of protein S deficiency in Asian population, In Recent advances in thrombosis and hemostasis", pp.597~613 (2008), Springer
50. Bonthron D, "The human von Willebrand factor gene. Structure of the 5’ region", Eur J Biochem, 171, pp.51~57 (1988)
51. Mancuso DJ, "Human von Willebrand factor gene and pseudogene: structural analysis and differentiation by polymerase chain reaction", Biochemistry, 30, pp.253~269 (1991)
52. Johansson AM, "Large deletions of the PROS1 gene in a large fraction of mutation-negative patients with protein S deficiency", Thromb Haemost, 94, pp.951~957 (2005)
53. Lind-Halldén C, "Small and large PROS1 deletions but no other types of rearrangements detected in patients with protein S deficiency", Thromb Haemost, 108, pp.94~100 (2012)
54. Hamasaki N, "Unmasking Asian thrombophilia: is APC dysfunction the real culprit?", J Thromb Haemost, 10, pp.2016~2018 (2012)
55. Kimura R, "Plasma protein S activity correlates with protein S genotype but is not sensitive to identify K196E mutant carriers", J Thromb Haemost, 4, pp.2010~2013 (2006)
56. Tsuda T, "New quantitative total protein S-assay system for diagnosing of protein S type II deficiency: clinical application of the screening system for protein S type II deficiency", Blood Coagul Fibrinolysis, 23, pp.56~63 (2012)
57. Suzuki A, "Down-regulation of PROS1 gene expression by 17β-estradiol via estrogen receptor α (ERα)-Sp1 interaction recruiting receptor-interacting protein 140 and the corepressor-HDAC3 complex", J Biol Chem, 285, pp.13444~13453 (2010)
58. Drakenberg T, "Solution structure of the Ca2+-Binding EGF3-4 pair from vitamin K-dependent protein S: identification of an unusual fold in EGF3", Biochemistry, 44, pp.8782~8789 (2005)
59. Schwede T, "SWISS-MODEL: An automated protein homology-modeling server", Nucleic Acids Res, 31, pp.3381~3385 (2003)
60. Huang M, "Crystal structure of the calcium-stabilized human factor IX Gla domain bound to a conformation-specific anti-factor IX antibody", J Biol Chem, 279, pp.14338~14346 (2004)
61. Groebke Zbinden K, "Design of selective phenylglycine amide tissue factor", factor VIIa inhibitors, 2005, pp.15, 817~822
62. Sasaki T, "Crystal structure of a C-terminal fragment of growth arrest-specific protein Gas6. Receptor tyrosine kinase activation by laminin G-like domains", J Biol Chem, 277, pp.44164~44170 (2002)

관련 논문AI추천